Heart failure
Conditions
Interventions
Gold Standard:The patient exhibited typical symptoms and signs of heart failure
the key biomarker for heart failure, BNP, continued to rise by >=50%
and the cardiac ultrasound indicated a decrease in left ventricular ejection fraction (LVEF) by >=15% compared to the baseline value.
Index test:Hybrid Model Based on Transformer-GRU-GCN
Sponsors
Ningbo Zhenhai District People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients are required to meet the following criteria: they must have been diagnosed with acute myocardial infarction (STEMI/NSTEMI) according to the 2023 ESC guidelines and have undergone reperfusion therapy (TIMI flow grades 2-3), be aged between 18 and 85 years, have a baseline LVEF of =40%, and be able to cooperate with wearing a device for dynamic monitoring; they must also sign the relevant informed consent form.
Exclusion criteria
Exclusion criteria: Patients with end-stage heart failure (NYHA IV), severe hepatic and renal insufficiency (eGFR < 30 mL/min or Child-Pugh C), active malignancy, pregnancy, and missing key data were excluded. Interfering factors such as inability to tolerate wearable device monitoring or participation in other intervention trials were also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of heart failure incidence prediction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Readmission rate;Physician adoption rate; | — |
Countries
China
Contacts
Public ContactFeng Guanpeng
Ningbo Zhenhai District People's Hospital
Outcome results
None listed